Tag

Inventia Healthcare

All articles tagged with #inventia healthcare

Inventia Healthcare Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures
health9 hours ago

Inventia Healthcare Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures

Inventia Healthcare Limited has voluntarily recalled 13,567 bottles of chlorthalidone 25 mg tablets after the medication failed dissolution testing. This is the second recall for this specific drug by the India-based manufacturer in 2026, following an earlier action in June. The FDA has classified the recall as Class II, indicating that while the risk of serious harm is remote, the product may cause temporary or medically reversible adverse health consequences. Patients are advised to consult their healthcare providers before stopping the medication, as abrupt discontinuation could lead to dangerous spikes in blood pressure.

FDA classifies Inventia’s chlorthalidone recall as Class II after dissolution failures
health1 day ago

FDA classifies Inventia’s chlorthalidone recall as Class II after dissolution failures

The FDA has classified a nationwide recall of over 25,000 bottles of chlorthalidone 25 mg tablets as Class II, citing failures in dissolution specifications that may impair drug absorption. Manufactured by India-based Inventia Healthcare Limited, the affected batches were distributed across the United States. Patients are advised to consult their healthcare providers before discontinuing the medication, as stopping treatment may pose greater risks than continuing use of the recalled product.

FDA Upgrades Chlorthalidone Recall to Class II After Dissolution Failures
health1 day ago

FDA Upgrades Chlorthalidone Recall to Class II After Dissolution Failures

The FDA has escalated a nationwide recall of 13,567 bottles of chlorthalidone 25mg tablets to Class II status due to failures in dissolution specifications. Manufactured by Inventia Healthcare Limited, the affected medication was distributed across the US and is identified by NDC number 64980-599-01. This is the second recall for this specific drug in three months, following a similar issue with Rising Pharma Holdings in June. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.

FDA Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures
health2 days ago

FDA Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures

The FDA has issued a Class II recall for 13,567 bottles of chlorthalidone 25mg tablets manufactured by Inventia Healthcare Limited. The recall, initially issued on September 3 and upgraded on September 17, stems from the medication failing dissolution specifications, which may prevent the drug from releasing its active ingredient properly. This is the second recall for this specific medication in three months, following a similar issue with Rising Pharma Holdings in June. Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.

FDA Classifies Second Chlorthalidone Recall as Class II Due to Dissolution Failures
health2 days ago

FDA Classifies Second Chlorthalidone Recall as Class II Due to Dissolution Failures

The FDA has classified a second nationwide recall of chlorthalidone tablets as Class II, affecting over 13,000 bottles. Manufactured by Inventia Healthcare, the medication failed dissolution tests, potentially reducing its effectiveness for treating high blood pressure. Patients are advised to contact their healthcare providers before stopping the medication.